TY - JOUR
T1 - Degradation, bioactivity, and osteogenic potential of composites made of PLGA and two different sol-gel bioactive glasses
AU - Pamula, Elzbieta
AU - Kokoszka, Justyna
AU - Cholewa-Kowalska, Katarzyna
AU - Laczka, Maria
AU - Kantor, Lukasz
AU - Niedzwiedzki, Lukasz
AU - Reilly, Gwendolen C.
AU - Filipowska, Joanna
AU - Madej, Wojciech
AU - Kolodziejczyk, Malgorzata
AU - Tylko, Grzegorz
AU - Osyczka, Anna M.
PY - 2011/8
Y1 - 2011/8
N2 - We have developed poly(l-lactide-co-glycolide) (PLGA) based composites using sol-gel derived bioactive glasses (S-BG), previously described by our group, as composite components. Two different composite types were manufactured that contained either S2-high content silica S-BG, or A2-high content lime S-BG. The composites were evaluated in the form of sheets and 3D scaffolds. Sheets containing 12, 21, and 33 vol.% of each bioactive glass were characterized for mechanical properties, wettability, hydrolytic degradation, and surface bioactivity. Sheets containing A2 S-BG rapidly formed a hydroxyapatite surface layer after incubation in simulated body fluid. The incorporation of either S-BG increased the tensile strength and Young's modulus of the composites and tailored their degradation rates compared to starting compounds. Sheets and 3D scaffolds were evaluated for their ability to support growth of human bone marrow cells (BMC) and MG-63 cells, respectively. Cells were grown in non-differentiating, osteogenic or osteoclast-inducing conditions. Osteogenesis was induced with either recombinant human BMP-2 or dexamethasone, and osteoclast formation with M-CSF. BMC viability was lower at higher S-BG content, though specific ALP/cell was significantly higher on PLGA/A2-33 composites. Composites containing S2 S-BG enhanced calcification of extracellular matrix by BMC, whereas incorporation of A2 S-BG in the composites promoted osteoclast formation from BMC. MG-63 osteoblast-like cells seeded in porous scaffolds containing S2 maintained viability and secreted collagen and calcium throughout the scaffolds. Overall, the presented data show functional versatility of the composites studied and indicate their potential to design a wide variety of implant materials differing in physico-chemical properties and biological applications. We propose these sol-gel derived bioactive glass-PLGA composites may prove excellent potential orthopedic and dental biomaterials supporting bone formation and remodeling.
AB - We have developed poly(l-lactide-co-glycolide) (PLGA) based composites using sol-gel derived bioactive glasses (S-BG), previously described by our group, as composite components. Two different composite types were manufactured that contained either S2-high content silica S-BG, or A2-high content lime S-BG. The composites were evaluated in the form of sheets and 3D scaffolds. Sheets containing 12, 21, and 33 vol.% of each bioactive glass were characterized for mechanical properties, wettability, hydrolytic degradation, and surface bioactivity. Sheets containing A2 S-BG rapidly formed a hydroxyapatite surface layer after incubation in simulated body fluid. The incorporation of either S-BG increased the tensile strength and Young's modulus of the composites and tailored their degradation rates compared to starting compounds. Sheets and 3D scaffolds were evaluated for their ability to support growth of human bone marrow cells (BMC) and MG-63 cells, respectively. Cells were grown in non-differentiating, osteogenic or osteoclast-inducing conditions. Osteogenesis was induced with either recombinant human BMP-2 or dexamethasone, and osteoclast formation with M-CSF. BMC viability was lower at higher S-BG content, though specific ALP/cell was significantly higher on PLGA/A2-33 composites. Composites containing S2 S-BG enhanced calcification of extracellular matrix by BMC, whereas incorporation of A2 S-BG in the composites promoted osteoclast formation from BMC. MG-63 osteoblast-like cells seeded in porous scaffolds containing S2 maintained viability and secreted collagen and calcium throughout the scaffolds. Overall, the presented data show functional versatility of the composites studied and indicate their potential to design a wide variety of implant materials differing in physico-chemical properties and biological applications. We propose these sol-gel derived bioactive glass-PLGA composites may prove excellent potential orthopedic and dental biomaterials supporting bone formation and remodeling.
KW - Alkaline phosphatase
KW - Bioactive composites
KW - Bioactive glass
KW - Bone morphogenetic proteins
KW - Human bone marrow cells
KW - MG-63 cells
KW - Mineralization
KW - Osteoclasts
KW - Poly(l-lactide-co-glycolide)
KW - Sol-gel method
UR - http://www.scopus.com/inward/record.url?scp=80051551017&partnerID=8YFLogxK
U2 - 10.1007/s10439-011-0307-4
DO - 10.1007/s10439-011-0307-4
M3 - Article
C2 - 21487840
AN - SCOPUS:80051551017
SN - 0090-6964
VL - 39
SP - 2114
EP - 2129
JO - Annals of Biomedical Engineering
JF - Annals of Biomedical Engineering
IS - 8
ER -